- Home
- QSI vs TMCI Comparison
QSI vs TMCI Comparison
Compare QSI & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QSI
- TMCI
- Stock Information
- Founded
- QSI 2013
- TMCI 2014
- Country
- QSI United States
- TMCI United States
- Employees
- QSI N/A
- TMCI N/A
- Industry
- QSI Biotechnology: Pharmaceutical Preparations
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- QSI Health Care
- TMCI Health Care
- Exchange
- QSI Nasdaq
- TMCI Nasdaq
- Market Cap
- QSI 389.3M
- TMCI 344.1M
- IPO Year
- QSI N/A
- TMCI 2021
- Fundamental
- Price
- QSI $1.10
- TMCI $6.89
- Analyst Decision
- QSI Strong Buy
- TMCI Hold
- Analyst Count
- QSI 3
- TMCI 5
- Target Price
- QSI $2.38
- TMCI $8.60
- AVG Volume (30 Days)
- QSI 7.4M
- TMCI 388.1K
- Earning Date
- QSI 08-05-2025
- TMCI 08-07-2025
- Dividend Yield
- QSI N/A
- TMCI N/A
- EPS Growth
- QSI N/A
- TMCI N/A
- EPS
- QSI N/A
- TMCI N/A
- Revenue
- QSI $3,412,000.00
- TMCI $213,751,000.00
- Revenue This Year
- QSI $98.76
- TMCI $10.61
- Revenue Next Year
- QSI $213.39
- TMCI $10.41
- P/E Ratio
- QSI N/A
- TMCI N/A
- Revenue Growth
- QSI 100.47
- TMCI 7.67
- 52 Week Low
- QSI $0.61
- TMCI $4.54
- 52 Week High
- QSI $5.77
- TMCI $10.79
- Technical
- Relative Strength Index (RSI)
- QSI 24.54
- TMCI 69.82
- Support Level
- QSI $1.08
- TMCI $5.17
- Resistance Level
- QSI $1.99
- TMCI $7.04
- Average True Range (ATR)
- QSI 0.10
- TMCI 0.51
- MACD
- QSI -0.04
- TMCI 0.16
- Stochastic Oscillator
- QSI 2.78
- TMCI 80.51
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.